期刊文献+

妊娠糖尿病患者血清S100A4、FNDC5水平及其与妊娠结局的关系

Serum S100A4,FNDC5 levels in patients with gestational diabetes mellitus and their relationship with pregnancy outcome
下载PDF
导出
摘要 目的 探究妊娠糖尿病(GDM)患者血清S100钙结合蛋白A4(S100A4)、Ⅲ型纤连蛋白结构域包含蛋白5(FNDC5)水平及其与妊娠结局的关系。方法 选取2020年6月至2022年6月该院126例GDM患者作为GDM组,选取同期孕检的126例健康孕妇作为对照组。根据GDM患者妊娠结局情况分为妊娠结局良好组(76例)和妊娠结局不良组(50例)。采用酶联免疫吸附试验(ELISA)检测血清S100A4、FNDC5水平,采用Logistic回归分析GDM孕妇妊娠结局,采用受试者工作特征(ROC)曲线评估血清S100A4、FNDC5预测GDM孕妇妊娠不良结局的价值,采用Spearman相关性分析血清S100A4、FNDC5与不良妊娠结局的相关性。结果 GDM组血清S100A4水平明显高于对照组(P<0.05),血清FNDC5水平明显低于对照组(P<0.05)。妊娠结局良好组血清S100A4水平明显低于妊娠结局不良组(P<0.05),血清FNDC5水平明显高于妊娠结局不良组(P<0.05)。Spearman相关性分析结果显示,GDM患者血清S100A4水平与不良妊娠结局呈正相关(P<0.05),FNDC5水平与不良妊娠结局呈负相关(P<0.05)。Logistic回归分析表明,血清S100A4、空腹血糖、HOMA-IR是GDM患者发生不良妊娠结局的危险因素(P<0.05),FNDC5是GDM患者发生不良妊娠结局的保护因素(P<0.05)。血清S100A4、FNDC5联合预测GDM妊娠结局的曲线下面积大于S100A4(Z=2.045,P=0.041)及FNDC5单项检测(Z=2.010,P=0.044)。结论 GDM患者血清S100A4水平升高,FNDC5水平降低,二者对评估GDM孕妇妊娠结局具有一定的参考价值。 Objective To investigate the serum S100 calcium-binding protein A4(S100A4)and fibronectin typeⅢdomain-containing 5(FNDC5)levels in patients with gestational diabetes mellitus(GDM)and their relationship with pregnancy outcomes.Methods From June 2020 to June 2022,a total of 126 patients with GDM in the hospital were included into GDM group,and 126 healthy pregnant women who underwent prenatal check ups during the same period were selected as the control group.According to the pregnancy outcome of GDM patients,they were grouped into a good pregnancy outcome group(76 cases)and a adverse pregnancy outcome group(50 cases).The levels of S100A4 and FNDC5 were detected by enzyme linked immunosorbent assay(ELISA).Multivariate Logistic regression analysis was applied to analyze the influencing factors of pregnancy outcome in GDM pregnant women.Receiver operating characteristic(ROC)curve was applied to evaluate the value of serum S100A4 and FNDC5 in predicting adverse pregnancy outcomes in GDM pregnant women.Spearman correlation analysis was applied to analyze the correlation between serum S100A4,FNDC5 and adverse pregnancy outcomes.Results The serum S100A4 level in GDM group was higher than that in control group(P<0.05),while the serum FNDC5 level was lower than that in control group(P<0.05).The serum S100A4 level in the good pregnancy outcome group was lower than that in the adverse pregnancy outcome group(P<0.05),while the serum FNDC5 level was higher than that in the adverse pregnancy outcome group(P<0.05).Spearman correlation analysis showed that serum S100A4 level in GDM patients was positively correlated with adverse pregnancy outcomes(P<0.05),while FNDC5 level was negatively correlated with adverse pregnancy outcomes(P<0.05).Logistic regression analysis showed that serum S100A4,fasting blood glucose,and HOMA-IR were risk factors for adverse pregnancy outcomes in GDM patients(P<0.05),and FNDC5 was a protective factor for adverse pregnancy outcomes in GDM patients(P<0.05).The area under the curve of the combination of serum S100A4 and FNDC5 in predicting pregnancy outcomes in GDM was greater than that of S100A4 alone(Z=2.045,P=0.041)and FNDC5 alone(Z=2.010,P=0.044).Conclusion The level of S100A4 in the serum of GDM patients is high,and the level of FNDC5 is low.Both have certain reference value for evaluating the pregnancy outcome of GDM pregnant women.
作者 刘静 周聪 何珊 LIU Jing;ZHOU Cong;HE Shan(Department of Obstetrics and Gynecology,Xiantao First People′s Hospital Affiliated to Yangtze University,Xiantao,Hubei 433000,China;Department of Pediatrics,Jingmen Rehabilitation Hospital,Jingmen,Hubei 448000,China)
出处 《国际检验医学杂志》 CAS 2024年第13期1617-1621,1626,共6页 International Journal of Laboratory Medicine
关键词 妊娠糖尿病 S100钙结合蛋白A4 Ⅲ型纤连蛋白结构域包含蛋白5 妊娠结局 gestational diabetes mellitus S100 calcium-binding protein A4 fibronectin typeⅢdomain-containing 5 pregnancy outcome
  • 相关文献

二级参考文献92

  • 1麦彩园,李慧,陈嵘,袁力,段冬梅,林小红,温济英.妊娠期糖尿病的危险因素对妊娠结局的影响[J].广东医学,2019,40(S01):69-72. 被引量:10
  • 2Kahn CR.Joslin糖尿病学[M].14版.潘长玉,主译.北京:人民卫生出版社,2005:550-552.
  • 3中华医学会妇产科学分会产科学组,中华医学会围产医学分会妊娠合并糖尿病协作组.妊娠合并糖尿病临床诊断与治疗推荐指南(草案)[J].中华妇产科杂志,2007,42:426-428.
  • 4中华人民共和国国家卫生部.WS331-2011妊娠期糖尿病诊断[s]北京:中华人民共和国国家卫生部,2011.
  • 5International Association of Diabetes and Pregnancy 3tudy Groups Consensus Panel,Metzger BE,Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy[J].Diabetes Care,2010,33:676-682.
  • 6International Diabetes Federation. Global Guideline on Pregnancy and Diabetes[S].Brussels: International Diabetes Federation,2009.
  • 7Walker JD. Diabetes in pregnancy:management of diabetes and its complications from pre-conception to the postnatal period. NICE guideline 63. London, March 2008[J]. Diabet Med, 2008, 25: 1025-1027.
  • 8Hoffman L,Nolan C,Wilson JD,et al.Gestational diabetes mellitus-management guidellnes.The Australasian Diabetes in Pregnancy Society[J].Med J Aust, 1998,169:93-97.
  • 9Canadian Diabetes Association.2008 CDA clinical practiceguidelines for the prevention and management of diabetes in Canada[J].Can J Diabetes,2008,32:S168-180.
  • 10Hadar E,Oats J,Hod M.Towards new diagnostic criteria for diagnosing GDM:the HAPO study[J].J Perinat Med, 2009, 37: 447-449.

共引文献1501

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部